Article Details

Pfizer reports durable second-season efficacy for RSV vaccine - CIDRAP

Retrieved on: 2024-02-29 20:10:50

Tags for this article:

Click the tags to see associated articles and topics

Pfizer reports durable second-season efficacy for RSV vaccine - CIDRAP. View article details on hiswai:

Summary

The article highlights how epidemiology informs us that safety net hospitals have a 30% higher risk of surgical-site infections after gastrointestinal surgeries, underscoring challenges in health care quality and the need for healthcare reform in the U.S.

Article found on: www.cidrap.umn.edu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up